Table 1.
Combined MRI/mammography, mammography and unscreened BRCA2 mutation carriers survival from diagnosis
| Number | 10-year survival all causes (95 % CI) | Log Rank (Mantel-Cox) P value for overall survival compared to unscreened | 10-year survival breast cancer (95 % CI) | Log Rank (Mantel-Cox) P value overall survival compared to unscreened | |
|---|---|---|---|---|---|
| Unscreened | 274 | 70.8 (62.2 to 79.4) | 74.6 (66.6 to 82.6) | ||
| MRI/mammography | 34 | 100 % | 0.026 | 100 % | 0.035 |
| 6 prevalent | |||||
| 26 incident | |||||
| 2 Interval | |||||
| Mammography | 53 | 85.5 (72.6 to 98.4) | 0.142 | 85.5 (72.6 to 98.4) | 0.196 |
| 9 prevalent | |||||
| 36 incident | |||||
| 8 Interval | |||||
| Any screening | 87 (5 detected on mammography only in MRI group and 6 with both modalities) | 89.5 (79.5 to 99.5) | 0.017 | 89.5 (79.5 to 99.5) | 0.029 |